Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...

The Sabin Center’s Climate Backtracker shows that, as of January 14, 2026, the Trump administration has taken nearly 300 actions to scale back or halt climate and clean energy progress. UCS’s ...

Google launched four official and confirmed algorithmic updates in 2025, three core updates and one spam update. This is in comparison to last year, in 2024, where we had seven confirmed updates, then ...

With finals over and done with, I’ve been spending my extra free time doom-scrolling on Instagram Reels. Now that I have more time on my hands, I’ve noticed just how many additions Reels has had in ...

Instagram is introducing a new tool that lets you see and control your algorithm, starting with Reels, the company announced on Wednesday. The new tool, called “Your Algorithm,” lets you view the ...

You chose selected. Each dot here represents a single video about selected. While you’re on the app, TikTok tracks how you interact with videos. It monitors your watch time, the videos you like, the ...

Recursion Pharmaceuticals is currently showing a mixed technical picture for traders. The stock is trading 12.2% above its 20-day SMA, which suggests some short-term strength, but it’s struggling ...

Monday - Friday, 6:00 - 7:00 PM ET It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

Recursion Pharmaceuticals remains a high-cash-burn, premium-valued biotech with unproven clinical success despite a recent 47% rally. RXRX's next 18 months are catalyst-rich, but key pipeline assets ...